Fort Collins, CO, United States of America

Charles R Martin


Average Co-Inventor Count = 3.1

ph-index = 3

Forward Citations = 34(Granted Patents)


Location History:

  • Bryan, TX (US) (1988 - 1993)
  • Fort Collins, CO (US) (1992 - 1998)

Company Filing History:


Years Active: 1988-1998

Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Charles R. Martin

Introduction

Charles R. Martin is a notable inventor based in Fort Collins, Colorado. He has made significant contributions to the field of chemistry, particularly in the synthesis of cephalosporin antibiotics. With a total of six patents to his name, Martin's work has had a lasting impact on pharmaceutical development.

Latest Patents

Among his latest patents, Martin has developed a process for the preparation of intermediates useful in the synthesis of 3-exomethylene cephalosporanic acid derivatives. This process is crucial for the production of cephalosporin antibiotics, such as ceftibuten. The method involves the electrochemical reduction of specific compounds, resulting in the desired 3-exomethylene compounds with minimal levels of the corresponding 3-methyl tautomers.

Career Highlights

Throughout his career, Martin has worked with prominent companies in the chemical and pharmaceutical industries. Notably, he has been associated with The Dow Chemical Company and Schering Corporation. His experience in these organizations has contributed to his expertise in chemical processes and innovations.

Collaborations

Martin has collaborated with several professionals in his field, including Derek Walker and Junning Lee. These partnerships have likely enhanced his research and development efforts, leading to successful innovations.

Conclusion

Charles R. Martin's contributions to the field of chemistry and his innovative patents in antibiotic synthesis underscore his importance as an inventor. His work continues to influence the pharmaceutical industry and improve healthcare outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…